Long-Term Complete Response to Pembrolizumab in Tumor Mutation Burden-High Small Cell Lung Cancer: A Case Report

Long-Term Complete Response to Pembrolizumab in Tumor Mutation Burden-High Small Cell Lung Cancer: A Case Report

Introduction: Extensive-stage small-cell lung cancer (ED-SCLC) has a poor prognosis. There are few case reports on the therapeutic effect of pembrolizumab in advanced SCLC with high tumor mutation burden (TMB-high). Case Presentation: A 65-year-old woman was diagnosed with ED-SCLC. The in...

Full description

Saved in:
Bibliographic Details
Main Authors: Kiyohide Komuta, Kei Kunimasa, Akito Miyazaki, Shun Futamura, Tsunehiro Tanaka, Takahisa Kawamura, Takako Inoue, Motohiro Tamiya, Kazumi Nishino
Format: Article
Language:English
Published: Karger Publishers 2025-03-01
Series:Case Reports in Oncology
Online Access:https://karger.com/article/doi/10.1159/000544103
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items